ALK, the world's leading allergen extract manufacturer,announces the acquisition of Bio-Medical Services, a veterinary reference laboratory who pioneered in vitro serum IgE allergy testing in the veterinary industry.
Since 1923, ALK has exemplified scientific leadership in the field of allergy research, and has remained committed to the treatmentof allergic disease in humans. Bio-Medical Services introduced in Vitro serum IgE allergy testing to the veterinary industry in 1989, and has a proven track record for treating allergic disease for dogs, cats and horses. With this acquisition, ALK is now positioned to expand its allergy focus to include the very important veterinary allergy market.
The ACTT Allergy Program with ALK will include serum IgE allergy testing, bulk allergen sales for the veterinary dermatologist, and allergen-specific immunotherapy treatment, including the new ACTT Allergy Drops®, sublingual immunotherapy. Together, ALK and Bio-Medical Services will fight the cause of allergic disease for people and their pets.